The Food Safety and Standards Authority of India has initiated a comprehensive FSSAI food safety crackdown to eliminate severe regulatory non-compliances across the country. Recent regulatory audits led to immediate enforcement actions against food business operators in Tripura and Punjab. These measures underscore the authority's commitment to maintaining strict quality parameters in public food and health supplement sectors. Consequently, healthcare providers and consumers must stay informed regarding regulatory actions that directly impact patient safety and therapeutic integrity.

FSSAI Food Safety Crackdown on Packaged Drinking Water Lapses

The regulatory body suspended the operating license of M/S Matri Drinking Water in Gomati, Tripura, following formal consumer complaints. Official inspections revealed severe hygienic deficiencies that posed direct biological and chemical risks to consumers. Inspectors observed finished water bottles stored directly on unhygienic floors alongside non-food materials, exposing products to environmental contamination. Furthermore, processing and filling environments exhibited structural neglect, including damaged walls, peeling paint, cobwebs, and absent pest control protocols.

Additionally, audit teams discovered rusted reverse osmosis storage tanks and corroded chemical dosing containers in active production areas. The facility also failed to present mandatory water quality testing records, maintenance logs, and staff sanitation training documentation. Furthermore, no qualified technical supervisor was present during the inspection to manage quality assurance protocols. Consequently, the regulator halted all manufacturing activities at the facility under statutory powers to protect public health. This firm enforcement demonstrates that routine packaged water production requires consistent monitoring, robust filtration infrastructure, and strict adherence to sanitary operating guidelines.

Regulatory Findings on Unapproved Botanical and Active Ingredients

In a parallel regulatory action, authorities issued a strict prohibition order against Noble Healthcare, located in Mohali, Punjab. The regulatory order banned the manufacturing, storage, distribution, and sale of the product marketed as Venolex Forte. Investigations revealed that the dietary supplement contained pharmacologically active substances that are strictly prohibited in food formulations. Specifically, the manufacturer incorporated Calcium Dobesilate, Diosmin, and Euphorbia prostrata into a product registered under food supplement regulations.

Under the Food Safety and Standards Regulations 2022, food supplements cannot contain synthetic active pharmaceutical ingredients or restricted botanical extracts. Calcium Dobesilate and Diosmin function as active vasoactive drugs rather than standard dietary nutrients. Consequently, introducing active pharmaceutical agents into over-the-counter health supplements bypassing clinical prescription protocols creates severe health risks. The regulatory body highlighted that selling prescription-grade molecules as routine dietary supplements violates statutory framework guidelines. Therefore, manufacturers must strictly segregate pharmaceutical manufacturing from health supplement production to ensure patient safety and product integrity.

Exceeding RDA Limits and Misleading Supplement Labeling Risks

The investigation into Venolex Forte also uncovered significant nutritional formulation violations regarding micronutrient concentration limits. The regulator observed that each serving contained 90 mg of Vitamin C, which significantly exceeds the Recommended Dietary Allowance prescribed by national guidelines. According to the ICMR-NIN 2020 guidelines, daily dietary supplements must strictly align with recommended nutrient intake thresholds. Excessive micronutrient fortification without clinical justification can lead to undesirable metabolic effects and organ stress in vulnerable populations.

Furthermore, the regulator condemned misleading labeling practices that misinform consumers and medical professionals alike. The manufacturer prominently displayed its food license registration number beneath the product name, creating a false impression of official product endorsement. In addition, the packaging carried ambiguous therapeutic claims regarding vascular health without valid scientific substantiation. Consequently, the authority reiterated that food supplement labels must maintain complete transparency and avoid therapeutic disease claims. Healthcare practitioners must evaluate supplement labels critically to ensure their patients do not consume unapproved pharmaceutical combinations inadvertently.

Clinical Implications of Unregulated Phlebotonics and Contaminants

Unregulated distribution of active pharmaceutical ingredients poses significant therapeutic hazards to clinical practice. Phlebotonic agents like Diosmin and Calcium Dobesilate alter microvascular permeability and venous tone. Consequently, when patients consume these active compounds without medical supervision, unforeseen drug interactions and adverse vascular events can occur. Furthermore, patients with renal impairment or underlying hematological disorders face heightened risks from unmonitored pharmacological intake. Therefore, clinicians must remain vigilant when patients report taking over-the-counter dietary formulations for chronic venous disorders.

Simultaneously, contaminated packaged drinking water introduces substantial risks of gastrointestinal infections and toxic chemical exposure. Rusted processing equipment and poor pest control measures foster microbial growth and heavy metal toxicity in drinking water. Consequently, consuming unsafe bottled water can exacerbate systemic inflammation and complicate preexisting medical conditions. Medical practitioners frequently encounter patients presenting with unexplained acute gastroenteritis or chronic systemic toxicity tied to contaminated water sources. Thus, regulatory surveillance serves as an essential public health barrier against widespread environmental contamination and unregulated drug exposure.

Navigating Compliance and Safeguarding Public Health Standards

Sustained compliance across food manufacturing and dietary supplement sectors requires rigorous oversight and administrative transparency. The recent prohibition orders reflect a broader enforcement initiative by national authorities to clean up consumer health supply chains. Consequently, food business operators must implement comprehensive quality management systems, routine laboratory testing, and stringent sanitation schedules. Furthermore, health supplement manufacturers must ensure that all ingredients comply fully with approved national nutraceutical schedules before commercial release.

For healthcare providers, these regulatory actions highlight the necessity of detailed patient history taking during clinical consultations. Practitioners should routinely inquire about patient dietary supplement usage, including brand names and labeling details. In addition, reporting suspected adverse events from health supplements to regulatory channels strengthens post-market surveillance. By working collaboratively with regulatory frameworks, medical professionals can help identify mislabeled products and protect community health. Ultimately, rigorous enforcement paired with clinical vigilance establishes a safer environment for patients and consumers nationwide.

Frequently Asked Questions

Q1: Why did the regulator suspend the license of Matri Drinking Water in Tripura?

The regulator suspended the license of Matri Drinking Water due to severe food safety and hygiene violations. Official inspections revealed foreign particles in packaged water, rusted storage tanks, peeling paint, and cobwebs in processing areas. Additionally, finished water bottles were stored improperly on bare floors next to non-food items, creating contamination risks. The manufacturer also failed to maintain required water quality testing records and sanitation documentation.

Q2: What specific violations led to the prohibition order against Venolex Forte?

The authority prohibited Venolex Forte because it contained pharmacologically active ingredients not permitted in dietary supplements, including Calcium Dobesilate, Diosmin, and Euphorbia prostrata. Furthermore, the product contained 90 mg of Vitamin C, exceeding the recommended dietary allowance under ICMR-NIN 2020 guidelines. Additionally, the manufacturer used misleading labeling that falsely implied official product approval, violating food supplement regulations.

Q3: What are the clinical risks of unapproved active ingredients in food supplements?

Unapproved active pharmaceutical ingredients like Calcium Dobesilate and Diosmin in over-the-counter supplements can cause unexpected side effects and drug interactions. Patients consuming these substances without medical guidance risk adverse vascular effects, hepatic stress, or renal complications. Furthermore, inaccurate dosing and misleading therapeutic claims prevent patients from seeking proper medical care for chronic conditions like venous insufficiency.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. - ETHealthworld
2. Food Safety and Standards Authority of India (FSSAI). Enforcement Orders and Press Releases on Food Business Operators, 2026.
3. ICMR-National Institute of Nutrition (NIN). Nutrient Requirements and Recommended Dietary Allowances for Indians, 2020.